Neximmune Inc. (NEXI) NASDAQ
$3.40 - (-)
Market Cap: $4.66M
As of 05/14/24 12:00 AM EDT. Market closed.
Neximmune Inc. (NEXI)
NASDAQ
$3.40
- (-)
Market Cap: $4.66M
As of 05/14/24 12:00 AM EDT. Market closed.
Add to Portfolio
neximmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary aim™ technology. this nanotechnology platform, originally developed at johns hopkins university, is the foundation for an innovative approach to immunotherapy in which the body’s own immune system is stimulated to orchestrate a targeted t cell response against a disease. ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
68
Address
.
PRICE CHART FOR NEXIMMUNE INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$3.40
Days Range
$3.40 - $3.49
52 week range
$1.25 - $28.69
Volume
1,712
Avg. Volume (30 days)
19,743
Market Cap
$4.66M
Dividend Yield
-
P/E
-
Shares Outstanding
1,371,051
Open
-
Previous Close
$3.40
Days Range
$3.40 - $3.49
52 week range
$1.25 - $28.69
Volume
1,712
Avg. Volume (30 days)
19,743
Market Cap
$4.66M
Dividend Yield
-
P/E
-
Shares Outstanding
1,371,051
FINANCIAL STATEMENTS FOR NEXIMMUNE INC
LOADING...
INSIDER TRANSACTIONS FOR NEXIMMUNE INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
BARER SOL J | Director | Mar 30, 2023 | Buy | $0.41 | 400,000 | 164,120 | 2,217,814 | Mar 31, 2023, 04:56 PM |
BARER SOL J | Director | Nov 16, 2022 | Buy | $0.48 | 125,000 | 60,300 | 1,742,814 | Nov 17, 2022, 08:40 PM |
BARER SOL J | Director | Nov 17, 2022 | Buy | $0.48 | 75,000 | 35,917 | 1,817,814 | Nov 17, 2022, 08:40 PM |
Verstandig Grant | Director | Jun 03, 2022 | Buy | $2.22 | 15,000 | 33,374 | 1,053,619 | Jun 07, 2022, 06:17 PM |
Verstandig Grant | Director | Jun 06, 2022 | Buy | $2.14 | 25,000 | 53,537 | 1,078,619 | Jun 07, 2022, 06:17 PM |
Verstandig Grant | Director | Jun 07, 2022 | Buy | $2.28 | 26,876 | 61,385 | 1,105,495 | Jun 07, 2022, 06:17 PM |
Verstandig Grant | Director | May 31, 2022 | Buy | $2.11 | 45,024 | 95,118 | 950,519 | Jun 02, 2022, 07:42 PM |
Verstandig Grant | Director | Jun 01, 2022 | Buy | $2.38 | 40,200 | 95,760 | 990,719 | Jun 02, 2022, 07:42 PM |
Verstandig Grant | Director | Jun 02, 2022 | Buy | $2.23 | 47,900 | 106,683 | 1,038,619 | Jun 02, 2022, 07:42 PM |
BARER SOL J | Director | May 31, 2022 | Buy | $2.19 | 39,280 | 85,894 | 1,557,094 | Jun 02, 2022, 07:41 PM |
BARER SOL J | Director | Jun 01, 2022 | Buy | $2.35 | 40,000 | 94,160 | 1,597,094 | Jun 02, 2022, 07:41 PM |
BARER SOL J | Director | Jun 02, 2022 | Buy | $2.22 | 20,720 | 46,100 | 1,617,814 | Jun 02, 2022, 07:41 PM |
Jones Kristi | President and CEO | Mar 29, 2022 | Buy | $3.74 | 10,000 | 37,400 | 73,078 | Mar 30, 2022, 07:57 PM |
Verstandig Grant | Director | Mar 28, 2022 | Buy | $3.76 | 18,983 | 71,376 | 905,495 | Mar 28, 2022, 04:15 PM |
Verstandig Grant | Director | Mar 25, 2022 | Buy | $4.14 | 131,622 | 544,915 | 886,512 | Mar 28, 2022, 04:15 PM |
Verstandig Grant | Director | Mar 24, 2022 | Buy | $3.35 | 39,995 | 133,983 | 754,890 | Mar 28, 2022, 04:15 PM |
BARER SOL J | Director | Mar 23, 2022 | Buy | $2.67 | 10,000 | 26,653 | 1,517,814 | Mar 24, 2022, 04:15 PM |
BARER SOL J | Director | Mar 22, 2022 | Buy | $2.41 | 30,000 | 72,300 | 1,507,814 | Mar 23, 2022, 04:15 PM |
BARER SOL J | Director | Mar 21, 2022 | Buy | $2.14 | 30,000 | 64,080 | 1,477,814 | Mar 22, 2022, 04:15 PM |
BARER SOL J | Director | Mar 18, 2022 | Buy | $2.11 | 30,000 | 63,210 | 1,447,814 | Mar 21, 2022, 04:10 PM |
Roemer Alan S. | Director | Dec 21, 2021 | Option Exercise | $3.63 | 67,657 | 245,867 | 195,641 | Dec 22, 2021, 05:00 PM |
BARER SOL J | Director | Dec 21, 2021 | Option Exercise | $5.17 | 50,000 | 258,500 | 1,417,814 | Dec 22, 2021, 08:00 AM |
Trainer John | Chief Financial Officer | Jul 08, 2021 | Option Exercise | $5.17 | 3,432 | 17,743 | 61,770 | Jul 09, 2021, 04:19 PM |
Trainer John | Chief Financial Officer | May 08, 2021 | Option Exercise | $5.17 | 3,432 | 17,743 | 54,906 | May 19, 2021, 04:16 PM |
Trainer John | Chief Financial Officer | Apr 08, 2021 | Option Exercise | $5.17 | 3,432 | 17,743 | 51,474 | May 19, 2021, 04:16 PM |
Trainer John | Chief Financial Officer | Mar 10, 2021 | Option Exercise | $5.17 | 3,432 | 17,743 | 48,042 | Mar 12, 2021, 02:00 PM |
Jones Kristi | Chief Operating Officer | Feb 17, 2021 | Buy | $17.00 | 911 | 15,487 | 63,078 | Feb 19, 2021, 04:30 PM |
ZELDIS JEROME B | Executive VP of Research & Dev | Feb 17, 2021 | Buy | $17.00 | 5,882 | 99,994 | 5,882 | Feb 19, 2021, 04:30 PM |
Verstandig Grant | Director | Feb 17, 2021 | Buy | $17.00 | 175,000 | 2,975,000 | 714,895 | Feb 19, 2021, 04:25 PM |
BARER SOL J | Director | Feb 17, 2021 | Buy | $17.00 | 60,000 | 1,020,000 | 1,538,013 | Feb 19, 2021, 04:20 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
BARER SOL J | Director | 03/30/2023 | 164,120 |
BARER SOL J | Director | 11/16/2022 | 60,300 |
BARER SOL J | Director | 11/17/2022 | 35,917 |
Verstandig Grant | Director | 06/03/2022 | 33,374 |
Verstandig Grant | Director | 06/06/2022 | 53,537 |
Verstandig Grant | Director | 06/07/2022 | 61,385 |
Verstandig Grant | Director | 05/31/2022 | 95,118 |
Verstandig Grant | Director | 06/01/2022 | 95,760 |
Verstandig Grant | Director | 06/02/2022 | 106,683 |
BARER SOL J | Director | 05/31/2022 | 85,894 |
BARER SOL J | Director | 06/01/2022 | 94,160 |
BARER SOL J | Director | 06/02/2022 | 46,100 |
Jones Kristi | President and CEO | 03/29/2022 | 37,400 |
Verstandig Grant | Director | 03/28/2022 | 71,376 |
Verstandig Grant | Director | 03/25/2022 | 544,915 |
Verstandig Grant | Director | 03/24/2022 | 133,983 |
BARER SOL J | Director | 03/23/2022 | 26,653 |
BARER SOL J | Director | 03/22/2022 | 72,300 |
BARER SOL J | Director | 03/21/2022 | 64,080 |
BARER SOL J | Director | 03/18/2022 | 63,210 |
Roemer Alan S. | Director | 12/21/2021 | 245,867 |
BARER SOL J | Director | 12/21/2021 | 258,500 |
Trainer John | Chief Financial Officer | 07/08/2021 | 17,743 |
Trainer John | Chief Financial Officer | 05/08/2021 | 17,743 |
Trainer John | Chief Financial Officer | 04/08/2021 | 17,743 |
Trainer John | Chief Financial Officer | 03/10/2021 | 17,743 |
Jones Kristi | Chief Operating Officer | 02/17/2021 | 15,487 |
ZELDIS JEROME B | Executive VP of Research & Dev | 02/17/2021 | 99,994 |
Verstandig Grant | Director | 02/17/2021 | 2,975,000 |
BARER SOL J | Director | 02/17/2021 | 1,020,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN NEXIMMUNE INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ADAGE CAPITAL PARTNERS GP, L.L.C. | 32,054 | 0.00015% | Exited | Other |
BLACKROCK INC. | 14 | 0% | Exited | Other |
CHANGE IN SHARES OUTSTANDING FOR NEXIMMUNE INC
STOCK BUYBACKS FOR NEXIMMUNE INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.51%
1Q
06/30/2023
1.97%
2Q
03/31/2023
1.97%
3Q
12/31/2022
1.91%
4Q
09/30/2022
8.94%
5Q
06/30/2022
16.27%
6Q
03/31/2022
16.44%
7Q
12/31/2021
16.94%
8Q
09/30/2021
17.39%
9Q
06/30/2021
17.62%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEXIMMUNE INC
LOADING...